Related Experiment Video
Updated: Aug 16, 2025

Isolating Potentiated Hsp104 Variants Using Yeast Proteinopathy Models
Published on: November 11, 2014
Identification of HSPB8 modulators counteracting misfolded protein accumulation in neurodegenerative diseases
Marta Chierichetti1, Mauro Cerretani2, Alina Ciammaichella3
1Dipartimento di Scienze Farmacologiche e Biomolecolari, Università degli Studi di Milano, Milan, Italy.
Aims:
The small Heat Shock Protein B8 (HSPB8) is the core component of the Chaperone-Assisted Selective Autophagy (CASA) complex. This complex selectively targets, transports, and tags misfolded proteins for their recognition by autophagy receptors and insertion into the autophagosome for clearance. CASA is essential to maintain intracellular proteostasis, especially in heart, muscle, and brain often exposed to various types of cell stresses. In neurons, HSPB8 protects against neurotoxicity caused by misfolded proteins in several models of neurodegenerative diseases; by facilitating autophagy, HSPB8 assists misfolded proteins degradation also counteracting proteasome overwhelming and inhibition.
Materials And Methods:
To enhance HSPB8 protective activity, we screened a library of approximately 120,000 small molecules to identify compounds capable of increasing HSPB8 gene transcription, translation, or protein stability.
Key Findings:
We found 83 active compounds active in preliminary dose-response assays and further classified them in 19 chemical classes by medicinal chemists' visual inspection. Of these 19 prototypes, 14 induced HSPB8 mRNA and protein levels in SH-SY5Y cells. Out of these 14 compounds, 3 successfully reduced the aggregation propensity of a disease-associated mutant misfolded superoxide dismutase 1 (SOD1) protein in a flow cytometry-based aggregation assay (Flow cytometric analysis of Inclusions and Trafficking (FloIT)) and induced the expression (mRNA and protein) of some autophagy receptors. Notably, the 3 hits were inactive in HSPB8-depleted cells, confirming that their protective activity is mediated by and requires HSPB8.
Significance:
These compounds may be highly relevant for a therapeutic approach in several human disorders, including neurodegenerative diseases, in which enhancement of CASA exerts beneficial activities.
Insights
Researchers identified novel compounds that enhance HSPB8 protein activity, crucial for clearing misfolded proteins in neurodegenerative diseases. These findings offer potential therapeutic strategies for conditions involving protein aggregation.
Area of Science:
- Cellular Biology
- Neuroscience
- Drug Discovery
Background:
- The Chaperone-Assisted Selective Autophagy (CASA) complex, with HSPB8 as its core, is vital for clearing misfolded proteins and maintaining proteostasis.
- HSPB8 protects neurons from toxicity in neurodegenerative disease models by promoting autophagy and degradation of misfolded proteins.
Purpose of the Study:
- To identify small molecules that enhance the protective activity of HSPB8.
- To discover compounds that increase HSPB8 gene transcription, translation, or protein stability.
Main Methods:
- Screening of approximately 120,000 small molecules to find activators of HSPB8.
- Assessing compound efficacy in SH-SY5Y cells for HSPB8 expression and in vitro assays for reducing protein aggregation.
Main Results:
- Identified 83 active compounds, further classified into 19 chemical classes.
- 14 compounds increased HSPB8 mRNA and protein levels; 3 of these reduced misfolded SOD1 aggregation and enhanced autophagy receptor expression.
- The protective effects of the 3 hit compounds were dependent on the presence of HSPB8.
Conclusions:
- The identified compounds show therapeutic potential for neurodegenerative diseases and other disorders characterized by protein misfolding.
- Enhancing CASA complex activity through these compounds may offer a novel treatment strategy.
Related Concept Videos
Amyloid Fibrils
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
Neural Regulation

